Impact of the New Jersey Breast Density Law on Imaging and Intervention Volumes and Breast Cancer Diagnosis.
OBJECTIVE
Increased breast density is acknowledged as an independent risk factor for breast cancer and may obscure malignancy on mammography. Approximately half of all mammograms depict dense breasts. Legislation related to mandatory breast density notification was first enacted in Connecticut in 2009. On May 1, 2014, New Jersey joined other states with similar legislation. The New Jersey breast density law (NJBDL) mandates that mammography reports acknowledge the relevance and masking effect of mammographic breast density. The aim of this study was to assess the impact of the NJBDL at one of the state's largest ACR-accredited breast centers.


METHODS
A retrospective chart review was performed to determine changes in imaging and intervention utilization and modality of cancer diagnosis after enactment of the legislation. Data for the present study were extracted from a review of all patients with core biopsy-proven malignancy at a large outpatient breast center between November 1, 2012, and October 31, 2015. Data were divided into the 18-month period before the implementation of the NJBDL (November 1, 2012 to April 30, 2014) and the 18-month period after passage of the law (May 1, 2014 to October 31, 2015).


RESULTS
Screening ultrasound increased significantly after the implementation of the NJBDL, by 651% (1,530 vs 11,486). MRI utilization increased by 59.3% (2,595 vs 4,134). A total of 1,213 cancers were included in the final analysis, 592 in the first time period and 621 after law implementation. Breast cancer was most commonly detected on screening mammography, followed by diagnostic mammography with ultrasound for palpable concern, in both time periods. Of the 621 cancers analyzed, 26.1% (n = 162) were found in patients 50 years of age or younger. Results demonstrated that with respect to how malignancies were detected, age and average mammographic density were both statistically significant (P = .002).


CONCLUSIONS
The NJBDL succeeded in publicizing the masking effect of dense breasts. The number of supplemental screening ultrasound and MRI examinations increased after the implementation of this legislation. An efficacy analysis affirmed the high sensitivity of screening MRI compared with other modalities. The use of MRI increased core biopsy efficiency and reduced the number of biopsies needed per cancer diagnosed.
Breast Center, Barnabas Health Ambulatory Care Center, Livingston, New Jersey; Rutgers New Jersey Medical School, Newark, New Jersey. Electronic address: lsanders@barnabashealth.org.
Linda M
LM
Sanders
Breast Center, Barnabas Health Ambulatory Care Center, Livingston, New Jersey.
Alexander B
AB
King
Department of Surgery, Saint Barnabas Medical Center, Livingston, New Jersey.
Koren S
KS
Goodman
D000071060:Breast Density; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D018563:Disease Notification / Q000331:legislation & jurisprudence*; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008327:Mammography; D008403:Mass Screening / Q000331:legislation & jurisprudence*; D009515:New Jersey; D010818:Practice Patterns, Physicians' / Q000331:legislation & jurisprudence*; D012307:Risk Factors
Breast; MRI; breast cancer; density; imaging; risk; screening